Attend the large-scale exhibition in Guangzhou

Harbin Weike Biotechnology Co., Ltd. (referred to as Harshou Weike) was established in 1992. It is a high-tech enterprise wholly owned by the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences (referred to as Harshou Research Institute). With a registered capital of 100 million RMB, the company engages in veterinary drug manufacturing, veterinary drug distribution, import and export of pharmaceutical products, operation of laboratory animals, engineering and technological research and experimental development, technical services, technology development, technology consulting, technology promotion, and online sales. Its primary focus is on the incubation and commercialization of scientific and technological achievements developed by Harshou Research Institute, as well as the post-incubation promotion of these products. Currently, over 75% of Harshou Weike’s employees hold college diplomas or higher degrees, including 2 researchers and 17 associate researchers; among them, 35 employees hold master’s or doctoral degrees.